NCT03042884

Brief Summary

The goal of this research study is to learn how useful a wearable exercise tracker watch is to monitor your physical activity. This is an investigational study. Up to 100 participants will be enrolled in this study. All will take part at MD Anderson.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 3, 2017

Completed
10 days until next milestone

Study Start

First participant enrolled

February 13, 2017

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2020

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

3.8 years

First QC Date

January 30, 2017

Last Update Submit

December 16, 2020

Conditions

Keywords

Benign NeoplasmsIn Situ NeoplasmsMalignant Neoplasms of Independent (Primary) Multiple SitesWearable exercise trackersQuestionnairesSurveys

Outcome Measures

Primary Outcomes (4)

  • Usefulness of Exercise Tracker in Acute Inpatient Rehabilitation Unit Per Edmonton Symptom Assessment Scale (ESAS-FS)

    Exercise tracker considered useful if at least 2/3 patients consider it as useful.

    14 days

  • Usefulness of Exercise Tracker as an Outpatient Per Edmonton Symptom Assessment Scale (ESAS-FS)

    Exercise tracker considered useful if at least 2/3 patients consider it as useful.

    14 days

  • Usefulness of Exercise Tracker in Acute Inpatient Rehabilitation Unit Per Patient Reported Outcomes Measurement Information System (PROMIS)

    Exercise tracker considered useful if at least 2/3 patients consider it as useful.

    14 days

  • Usefulness of Exercise Tracker as an Outpatient Per Patient Reported Outcomes Measurement Information System (PROMIS)

    Exercise tracker considered useful if at least 2/3 patients consider it as useful.

    14 days

Study Arms (2)

Wearable Exercise Trackers - Inpatient Group

EXPERIMENTAL

Questionnaires completed at baseline and within 24 hours of discharge. Participant given a wearable exercise tracker to be worn 24 hours a day while in the acute inpatient rehabilitation unit.

Behavioral: QuestionnairesDevice: Wearable Exercise Tracker Watch

Wearable Exercise Trackers - Outpatient Group

EXPERIMENTAL

Questionnaires completed at baseline and again in 14 days. Participant given a wearable exercise tracker to be worn 24 hours a day for 14 days.

Behavioral: QuestionnairesDevice: Wearable Exercise Tracker Watch

Interventions

QuestionnairesBEHAVIORAL

Inpatient Group: Participants complete a questionnaire about any symptoms they may have had in the past 24 hours. The questionnaire should take about 5 minutes to complete. Within 24 hours of being discharged, same questionnaire about symptoms and a questionnaire about experience with the wearable exercise tracker. These questionnaires should take about 10 minutes total to complete. Outpatient Group: Participants complete 2 questionnaires about any symptoms they may have had in the past 24 hours and their current level of physical function. These should take about 10 minutes total to complete. At the end of the 14-day period, participant called by the study staff to remind them to complete the same 2 questionnaires about symptoms and level of physical function. Participants complete another questionnaire about their experience with the wearable exercise tracker. These questionnaires should take about 15 minutes total to complete.

Also known as: Surveys
Wearable Exercise Trackers - Inpatient GroupWearable Exercise Trackers - Outpatient Group

Inpatient Group: Participants receive a wearable exercise tracker watch upon admission to acute inpatient rehabilitation unit. Participant to wear the exercise tracker watch on their wrist for 24 hours a day. Device to be returned within 24 hours before being discharged. Outpatient Group: Participants receive a wearable exercise tracker watch to wear on their wrist for 24 hours a day for 14 days. Device to be returned at next visit.

Wearable Exercise Trackers - Inpatient GroupWearable Exercise Trackers - Outpatient Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women with literacy as demonstrated by reading and signing informed consent form
  • At least 18 years of age, since the rehabilitation unit and physical medicine and rehabilitation clinic is open to patients 18 years of age or older
  • Patients admitted to the acute inpatient rehabilitation unit and those seen in the Physical Medicine and Rehabilitation outpatient clinic
  • Capable of completing questionnaire in English

You may not qualify if:

  • \) Patients currently using a wearable activity tracker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Amy Ng, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2017

First Posted

February 3, 2017

Study Start

February 13, 2017

Primary Completion

December 14, 2020

Study Completion

December 14, 2020

Last Updated

December 17, 2020

Record last verified: 2020-12

Locations